HC restrains Glenmark from doing anti-diabetes drugs business
Delhi High Court today restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, saying it has infringed patent of the American drug major Merck…